https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
Our results indicate that SGC are frequently prescribed for PsA and psoriasis patients. The occurrence of psoriatic flares appears to be low upon SGC exposure. In patients with a clear indication for SGC, e.g. in need of rapid anti-inflammatory therapy or bridging of therapies, the use of SGC should be considered in view of a low risk of skin flaring. It remains of importance to weigh risks for short- and long-term SGC-related side effects in clinical decision making. Our results indicate that SGC are frequently prescribed for
Like
Comment
Share
